Crystal structure of ABT-737 complexed with Bcl-xL:: implications for selectivity of antagonists of the Bcl-2 family

被引：213
|
作者：
Lee, E. F.
Czabotar, P. E.
Smith, B. J.
Deshayes, K.
Zobel, K.
Colman, P. M.
Fairlie, W. D.
机构：
[1] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia
[3] Genentech Inc, San Francisco, CA 94080 USA
来源：
CELL DEATH AND DIFFERENTIATION | 2007年 / 14卷 / 09期
关键词：
D O I：
10.1038/sj.cdd.4402178
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1711 / 1713
页数：3
相关论文
共 50 条
  • [1] Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family
    E F Lee
    P E Czabotar
    B J Smith
    K Deshayes
    K Zobel
    P M Colman
    W D Fairlie
    Cell Death & Differentiation, 2007, 14 : 1711 - 1713
  • [2] The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
    Witham, James
    Valenti, Melanie R.
    De-Haven-Brandon, Alexis K.
    Vidot, Susanne
    Eccles, Suzanne A.
    Kaye, Stan B.
    Richardson, Alan
    CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7191 - 7198
  • [3] The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells
    Allaman-Pillet, Nathalie
    Oberson, Anne
    Munier, Francis
    Schorderet, Daniel F.
    OPHTHALMIC GENETICS, 2013, 34 (1-2) : 1 - 13
  • [4] Radiochemosensitization of primary glioma stem cells by the Bcl-2/Bcl-xL inhibitor ABT-737
    Dheenadayalan, R.
    Firat, E.
    Niedermann, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 118 - 118
  • [5] A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
    Chauhan, D.
    Velankar, M.
    Brahmandam, M.
    Hideshima, T.
    Podar, K.
    Richardson, P.
    Schlossman, R.
    Ghobrial, I.
    Raje, N.
    Munshi, N.
    Anderson, K. C.
    ONCOGENE, 2007, 26 (16) : 2374 - 2380
  • [6] A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
    D Chauhan
    M Velankar
    M Brahmandam
    T Hideshima
    K Podar
    P Richardson
    R Schlossman
    I Ghobrial
    N Raje
    N Munshi
    K C Anderson
    Oncogene, 2007, 26 : 2374 - 2380
  • [7] ABT-737, an inhibitor of Bcl-2/Bcl-XL proteins, is cytotoxic in multiple myeloma cells.
    Kline, M
    Kimlinger, T
    Timm, M
    Haug, J
    Lust, JA
    Rajkumar, SV
    Kumar, S
    BLOOD, 2005, 106 (11) : 455A - 455A
  • [8] ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
    Ji-Yu Li
    Yu-Yang Li
    Wei Jin
    Qing Yang
    Zhi-Ming Shao
    Xing-Song Tian
    Journal of Experimental & Clinical Cancer Research, 31
  • [9] ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
    Li, Ji-Yu
    Li, Yu-Yang
    Jin, Wei
    Yang, Qing
    Shao, Zhi-Ming
    Tian, Xing-Song
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [10] Bcl-xL inhibitor ABT-737 reveals a dual role for Bcl-xL in synaptic transmission
    Hickman, John A.
    Hardwick, J. Marie
    Kaczmarek, Leonard K.
    Jonas, Elizabeth A.
    JOURNAL OF NEUROPHYSIOLOGY, 2008, 99 (03) : 1515 - 1522
12345